Merck KGaA (MKGAF)

OTCMKTS · Delayed Price · Currency is USD
141.27
-2.03 (-1.42%)
Dec 23, 2024, 4:00 PM EST
-10.61%
Market Cap 62.31B
Revenue (ttm) 23.38B
Net Income (ttm) 3.01B
Shares Out n/a
EPS (ttm) 6.90
PE Ratio 20.72
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 700
Open 147.10
Previous Close 143.30
Day's Range 141.27 - 147.10
52-Week Range 140.58 - 200.56
Beta 0.71
Analysts n/a
Price Target n/a
Earnings Date Mar 6, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a... [Read more]

Sector Healthcare
Founded 1668
Employees 62,908
Stock Exchange OTCMKTS
Ticker Symbol MKGAF
Full Company Profile

Financial Performance

In 2023, Merck KGaA's revenue was 20.99 billion, a decrease of -5.57% compared to the previous year's 22.23 billion. Earnings were 2.82 billion, a decrease of -15.09%.

Financial numbers in EUR Financial Statements

News

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

HUB internationally recognized pioneer in organoid development Acquisition expands MilliporeSigma’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potent...

7 days ago - Financial Post

Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor RelationsBelen...

5 weeks ago - Seeking Alpha

Merck KGaA continues focus on strengthening pipeline with external innovation, says CFO on drug trials

Merck KGaA CFO Helene von Roeder discusses the group's third-quarter earnings and its progress with drug trials.

5 weeks ago - CNBC

Merck KGaA Q3 earnings rise faster than expected on lower costs

Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by cost-cutting measures and temporarily lower spending on drug research and development.

5 weeks ago - Reuters

Merck KGaA Specifies Guidance Amid Soft Semiconductor Market

Merck KGaA posted earnings that topped estimates as its life science unit recovers from its post-pandemic slump alongside positive growth trends in its other two businesses.

5 weeks ago - BNN Bloomberg

Merck KGaA, Darmstadt, Germany and Intel Launch Academic Research Program in Europe for More Sustainable Semiconductor Manufacturing

Following the announcement of the multidisciplinary research program last year, the selection process for funded projects has been completed Six projects involving eleven scientific institutions from ...

6 weeks ago - Financial Post

Merck KGaA: A Continued Long-Term Upside Despite Some Lag

Merck KGaA is a healthcare/pharma company that I have been covering and investing in for about 2 years at this point. Q2 2024 was mixed-positive. Read more here.

7 weeks ago - Seeking Alpha

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Shares of Charter Communications, Inc. (NASDAQ: CHTR) rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and revenues. Charter Communications...

7 weeks ago - Benzinga

AI is driving semiconductor industry, says CEO Electronics at Merck KgaA

Kai Beckmann, a member of the executive board and the CEO Electronics at Merck KgaA, discusses the use of AI in the semiconductor industry.

2 months ago - CNBC International TV

AI is driving semiconductor industry, says CEO Electronics at Merck KgaA

Kai Beckmann, a member of the executive board and the CEO Electronics at Merck KgaA, discusses the use of AI in the semiconductor industry.

2 months ago - CNBC

Why This Pharma Boss Isn’t Chasing the Obesity Hype

Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

2 months ago - Financial Post

Merck KGaA Shares Jump on Expectations of AI Boost

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously expected over the medium term.

2 months ago - The Wall Street Journal

Merck KGaA Shares Jump on Expectations of AI Boost

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously expected over the medium term.

2 months ago - WSJ

Merck KGaA Sees Post-Covid Life Sciences Rebound, Eyes M&A

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial setbacks and trimmed the top end of guidance for its life sciences unit.

2 months ago - BNN Bloomberg

MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA

Facility consolidates biosafety testing, analytical development, and cell bank manufacturing services into single building New rapid test offering with Blazar® CHO Animal Origin Free (AOF) delivers re...

2 months ago - Financial Post

MilliporeSigma Launches Single-Use Reactor Designed to Accelerate Antibody Drug Conjugate Manufacturing

First scalable single-use mixer specifically designed for ADC manufacturing Increases efficiency by 70% compared to stainless steel or glass manufacturing methods Utilizes Ultimus® Film for superior l...

3 months ago - Financial Post

Germany’s DAX 40 has a new female CEO: Daimler Truck appoints Karin Radstrom as next head in rare move

Radstrom will become just the second female CEO of a DAX 40 firm, joining Belen Garijo, the head of pharmaceutical giant Merck KGaA.

3 months ago - Fortune

MilliporeSigma Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing

New Pharmaceutical Auxiliary Materials cGMP standard introduced for cell culture media manufacturing Company first in the industry to receive EXCiPACT Certification Company’s cell culture media produc...

4 months ago - Financial Post

Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the first patient has been dosed in the Phase III MyClad trial (NCT064635...

4 months ago - Business Wire

Merck KGaA (MKGAF) Q2 2024 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q2 2024 Results Conference Call August 1, 2024 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belen Lopez - Chair of Executive Board & CEO Helene...

5 months ago - Seeking Alpha

Merck KGaA: The Drop Makes The Upside All The Sweeter

Merck KGaA remains undervalued with strong fundamentals and diverse business portfolio in healthcare, life sciences, and electronics. The company has above-average margins compared to the broader mark...

6 months ago - Seeking Alpha

Merck KGaA, Darmstadt, Germany, Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the discontinuation of the Phase III randomized TrilynX study evaluating ...

6 months ago - Business Wire

Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced new research from the company's diverse oncology portfolio will be presented at the 2024 American ...

7 months ago - Business Wire